New pancreatic cancer pill could reshape treatment as early trial results stun researchers
A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.
Browse Tag
e0fb0cc3-daf8-5490-8cea-41c26a0bc350
1 Article